Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry
2005; 62: 593–602.
Bittner A, Egger HL, Erkanli A, Jane Costello E, Foley DL, Angold A. What do childhood anxiety disorders predict?
J Child Psychol Psychiatry
2007; 48: 1174–83.
James AC, James G, Cowdrey F, Soler A, Choke A. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev
2013; 6: CD004690.
Lesch K-P, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science
1996; 274: 1527–31.
Sen S, Burmeister M, Ghosh D. Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet
2004; 127B: 85–9.
Munafò MR, Freimer NB, Ng W, Ophoff R, Veijola J, Miettunen J, et al. 5-HTTLPR genotype and anxiety-related personality traits: a meta-analysis and new data. Am J Med Genet B Neuropsychiatr Genet
2009; 150B: 271–81.
Karg K, Burmeister M, Shedden K, Sen S. The serotonin transporter promoter variant (5-httlpr), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry
2011; 68: 444–54.
Eley TC, Sugden K, Corsico A, Gregory AM, Sham P, McGuffin P, et al. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry
2004; 9: 908–15.
Taylor SE, Way BM, Welch WT, Hilmert CJ, Lehman BJ, Eisenberger NI. Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology. Biol Psychiatry
2006; 60: 671–6.
Wilhelm K, Mitchell PB, Niven H, Finch A, Wedgwood L, Scimone A, et al. Life events, first depression onset and the serotonin transporter gene. Br J Psychiatry
2006; 188: 210–5.
Stein MB, Campbell-Sills L, Gelernter J. Genetic variation in 5HTTLPR is associated with emotional resilience. Am J Med Genet B Neuropsychiatr Genet
2009; 150B: 900–6.
Belsky J, Jonassaint C, Pluess M, Stanton M, Brummett B, Williams R. Vulnerability genes or plasticity genes. Mol Psychiatry
2009; 14: 746–54.
Hankin B, Nederhof E, Oppenheimer C, Jenness J, Young J, Abela J, et al. Differential susceptibility in youth: evidence that 5-HTTLPR x positive parenting is associated with positive affect “for better and worse”. Transl Psychiatry
2011; 1: e44.
Lester KJ, Eley TC. Therapygenetics: using genetic markers to predict response to psychological treatment for mood and anxiety disorders. Biol Mood Anxiety Disord
2013; 3: 1–16.
Eley TC, Hudson JL, Creswell C, Tropeano M, Lester KJ, Cooper P, et al. Therapygenetics: the 5HTTLPR and response to psychological therapy. Mol Psychiatry
2012; 17: 236–7.
Kohen R, Cain KC, Buzaitis A, Johnson V, Becker KJ, Teri L, et al. Response to psychosocial treatment in poststroke depression is associated with serotonin transporter polymorphisms. Stroke
2011; 42: 2068–70.
Bockting CL, Mocking RJ, Lok A, Koeter MW, Schene AH. Therapygenetics: the 5HTTLPR as a biomarker for response to psychological therapy?
2012; 18: 744–5.
Bryant R, Felmingham K, Falconer E, Benito L, Dobson-Stone C, Pierce K, et al. Preliminary evidence of the short allele of the serotonin transporter gene predicting poor response to cognitive behavior therapy in posttraumatic stress disorder. Biol Psychiatry
2010; 67: 1217–9.
Andersson E, Rück C, Lavebratt C, Hedman E, Schalling M, Lindefors N, et al. Genetic polymorphisms in monoamine systems and outcome of cognitive behavior therapy for social anxiety disorder. PLoS ONE
2013; 8: e79015.
Furmark T, Carlbring P, Hammer S, Wahlgren I, Ekselius L, Eriksson E, et al. Effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on the response to cognitive-behavior therapy in individuals with social anxiety disorder. Biol Psychiatry
2010; 67 (9 suppl): 1S–271S.
Hedman E, Andersson E, Ljótsson B, Andersson G, Schalling M, Lindefors N, et al. Clinical and genetic outcome determinants of Internet-and group-based cognitive behavior therapy for social anxiety disorder. Acta Psychiatr Scand
2012; 126: 126–36.
Knuts I, Esquivel G, Kenis G, Overbeek T, Leibold N, Goossens L, et al. Therapygenetics: 5-HTTLPR genotype predicts the response to exposure therapy for agoraphobia. Eur Neuropsychopharmacol
2014; 24: 1222–8.
Lonsdorf T, Ruck C, Bergstrom J, Andersson G, Ohman A, Lindefors N, et al. The COMTval158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder. BMC Psychiatry
2010; 10: 99.
Hudson JL, Keers R, Roberts S, Coleman JR, Breen G, Arendt K, et al. Clinical predictors of response to cognitive-behavioral therapy in pediatric anxiety disorders: the Genes for Treatment (GxT) study. J Am Acad Child Adolesc Psychiatry
2015; 54: 454–63.
Silverman WK, Albano AM. The Anxiety Disorders Interview Schedule for Children-IV (Child and Parent Versions).
Oxford University Press, 1996.
Schneider S, Unnewehr S, Margraf J. Kinder-DIPS für DSM-IV-TR. Diagnostisches Interview bei psychischen Störungen im Kindes-und Jugendalter [Child-DIPS for DSM-IV-TR. Diagnostic Interview for Psychiatric Disordes in Childhood and Adolescence].
Freeman B, Smith N, Curtis C, Huckett L, Mill J, Craig IW. DNA from buccal swabs recruited by mail: evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behav Genet
2003; 33: 67–72.
Genotek DNA. Laboratory Protocol for Manual Purification of DNA from 0.5mL of Sample.
DNS Genotek, 2015.
Purcell S, Cherny SS, Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics
2003; 19: 149–50.
Stata Statistical Software: release 11. Stata Corp LP, 2009.
Beevers CG, McGeary JE. Therapygenetics: moving towards personalized psychotherapy treatment. Trends Cogn Sci.
2011; 16: 11–2.
Duncan LE, Keller MC. A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry. Am J Psychiatry
2011; 168: 1041–9.
Hudson JL, Lester KJ, Lewis CM, Tropeano M, Creswell C, Collier DA, et al. Predicting outcomes following cognitive behaviour therapy in child anxiety disorders: the influence of genetic, demographic and clinical information. J Child Psychol Psychiatry.
2013; 54: 1086–94.